AVITA Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for AVITA Medical, Inc. (RCEL) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Jun 2021Jun 2020
Operating Activities
Net Income-48.59-61.85-35.38-26.67-26.58-42.03
Depreciation & Amortization2.041.130.630.290.720.47
Stock Based Compensation9.5213.508.387.005.660.00
Change in Working Capital0.00-4.68-6.57-0.27-5.861.72
Change in Accounts Receivable0.00-4.15-4.17-0.40-1.400.00
Change in Inventory0.81-2.16-3.69-0.37-0.750.00
Change in Accounts Payable2.750.340.810.28-1.330.00
Change in Other Working Capital0.001.324.61-0.46-4.520.00
Other Operating Activities5.834.494.616.375.0116.15
Net Cash from Operating Activities-31.20-48.94-38.01-19.09-25.87-22.73
Investing Activities
Capital Expenditures0.00-9.17-1.450.531.170.85
Purchases of Investments-13.3146.70-78.76-18.81-49.550.00
Sales/Maturities of Investments27.50-0.1681.81-18.81-0.280.00
Other Investing Activities-1.74-0.160.000.000.000.00
Net Cash from Investing Activities12.4537.361.61-19.33-1.17-0.85
Financing Activities
Debt Repayment0.000.000.000.00-0.01-0.04
Common Stock Issued2.153.511.610.9069.1181.70
Other Financing Activities14.943.510.660.00-5.11-5.08
Net Cash from Financing Activities14.943.5140.370.9064.0577.06
Summary
Effect of Forex Changes on Cash0.000.00-0.02-0.030.130.00
Net Change in Cash-3.81-8.073.97-37.5237.0153.48
Cash at Beginning of Period14.0522.1218.1655.7173.8420.37
Cash at End of Period10.2414.0522.1218.16110.9873.85
Free Cash Flow-31.20-58.11-39.46-19.62-27.04-23.58
Supplemental Disclosures
Interest Paid0.005.361.140.020.000.04
Income Taxes Paid0.000.040.040.020.040.00